H
Henrik Birgens
Researcher at Copenhagen University Hospital
Publications - 88
Citations - 4025
Henrik Birgens is an academic researcher from Copenhagen University Hospital. The author has contributed to research in topics: Population & Lactoferrin. The author has an hindex of 30, co-authored 88 publications receiving 3518 citations. Previous affiliations of Henrik Birgens include University of Copenhagen & Herlev Hospital.
Papers
More filters
Journal ArticleDOI
The thalassaemia syndromes
Henrik Birgens,Rolf Ljung +1 more
TL;DR: Two important issues are focused on, namely the biological and the clinical aspects of thalassaemia, which are now occurring with relatively high frequency in many non‐endemic areas.
Journal ArticleDOI
Results of NOPHO ALL2008 treatment for patients aged 1-45 years with acute lymphoblastic leukemia.
Nina Toft,Nina Toft,Henrik Birgens,Jonas Abrahamsson,Laimonas Griskevicius,Helene Hallböök,Mats Heyman,Tobias Wirenfeldt Klausen,Olafur G. Jonsson,K. Palk,Kaie Pruunsild,Petter Quist-Paulsen,Goda Vaitkeviciene,Kim Vettenranta,Ann Åsberg,Thomas Frandsen,Hanne Vibeke Marquart,Hans O. Madsen,Ulrika Norén-Nyström,Kjeld Schmiegelow +19 more
TL;DR: A pediatric-based protocol is tolerable and effective for young adults, despite their increased frequency of higher risk features, with significant differences only for non-high risk groups.
Journal ArticleDOI
A Dominant Mutation in the Gene Encoding the Erythroid Transcription Factor KLF1 Causes a Congenital Dyserythropoietic Anemia
Lionel Arnaud,Carole Saison,Virginie Helias,Nicole Lucien,Dominique Steschenko,Marie-Catherine Giarratana,Claude Préhu,Bernard Foliguet,Lory Montout,Alexandre G. de Brevern,Alain Francina,Pierre Ripoche,Odile Fenneteau,Lydie Da Costa,T. Peyrard,Gail Coghlan,Niels Ove Illum,Henrik Birgens,Hannah Tamary,Achille Iolascon,Jean Delaunay,Gil Tchernia,Jean-Pierre Cartron +22 more
TL;DR: The study of this disease-causing mutation in KLF1 provides further insights into the roles of this transcription factor during erythropoiesis in humans.
Journal ArticleDOI
Hemochromatosis mutations in the general population: iron overload progression rate.
Rolf Værn Andersen,Anne Tybjærg-Hansen,Anne Tybjærg-Hansen,Merete Appleyard,Merete Appleyard,Henrik Birgens,Henrik Birgens,Børge G. Nordestgaard,Børge G. Nordestgaard +8 more
TL;DR: Individuals in the general population with C282Y homozygosity at most demonstrate modest increases in transferrin saturation and ferritin levels, and clinically overt hemochromatosis is rare.
Journal ArticleDOI
Rituximab in chronic cold agglutinin disease: a prospective study of 20 patients
Claudia Schöllkopf,Lars Kjeldsen,Ole Weiss Bjerrum,Hans Torben Mourits-Andersen,Johan Lanng Nielsen,Bjarne Egelund Christensen,Bjarne Jensen,B. Pedersen,Ellen Birkerod Taaning,Tobias Wirenfeldt Klausen,Henrik Birgens +10 more
TL;DR: Previous findings of a favourable effect of rituximab in patients with CAD are confirmed, however, few patients will obtain CR and, in most patients, the effect will be transient.